{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:39:15Z","timestamp":1792841955462,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005242","name":"Universite de Montreal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.brachy.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:57:56Z","timestamp":1780430276000},"page":"924-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urethral dosimetry and urinary symptoms after prostate brachytherapy: Analyzing key predictive factors"],"prefix":"10.1016","volume":"25","author":[{"given":"Sabrina","family":"Djemhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Karim","family":"Benhacene Boudam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guila","family":"Delouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5267-3213","authenticated-orcid":false,"given":"Daniel","family":"Taussky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2026.05.001_bib0001","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2020.02.028","article-title":"Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: assessment of cohort and method effects","volume":"147","author":"Mylona","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0002","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.3390\/curroncol30060426","article-title":"Associations of clinical and dosimetric parameters with urinary toxicities after prostate brachytherapy: a long-term single-institution experience","volume":"30","author":"Ito","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0003","article-title":"Urethral and bladder dosimetry and urinary toxicity in prostate cancer patients undergoing SBRT with and without intra-prostatic boost","volume":"54","author":"Bhargava","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0004","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110568","article-title":"Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial","volume":"201","author":"Draulans","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0006","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ijrobp.2025.01.008","article-title":"The determinants of toxicity in the treatment of prostate cancer with a focal, intraprostatic \u201cmicroboost.\u201d","volume":"122","author":"Patel","year":"2025","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0007","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brachy.2007.03.003","article-title":"The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry","volume":"6","author":"Neill","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2026.05.001_bib0008","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2004.12.068","article-title":"Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity","volume":"62","author":"Allen","year":"2005","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0009","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-Dose-rate prostate brachytherapy: implications for establishing new Dose constraints for treatment planning","volume":"90","author":"Hathout","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5114\/jcb.2023.126315","article-title":"Validation of the bladder neck as an important organ at risk in prostate seed brachytherapy based on D2cc: a single-institution, retrospective review","volume":"15","author":"Wallace","year":"2023","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2026.05.001_bib0011","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1016\/j.ijrobp.2011.02.037","article-title":"Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis","volume":"81","author":"Zilli","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0012","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association Symptom Index for Benign Prostatic Hyperplasia","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0013","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0360-3016(00)00541-1","article-title":"Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy","volume":"47","author":"Thomas","year":"2000","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2010.01.022","article-title":"Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate","volume":"80","author":"Roeloffzen","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0016","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.clon.2006.02.007","article-title":"Prediction of urinary symptoms after 125Iodine prostate brachytherapy","volume":"18","author":"Kelly","year":"2006","journal-title":"Clin Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0017","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12894-025-01718-6","article-title":"Urinary function, sexual function and quality of life after prostate low-dose-rate brachytherapy: a retrospective analysis","volume":"25","author":"M\u00e4kel\u00e4","year":"2025","journal-title":"BMC Urol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0018","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.brachy.2020.06.011","article-title":"Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy","volume":"19","author":"Boyce-Fappiano","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2026.05.001_bib0019","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.acra.2023.09.004","article-title":"Prostatic urethral length on MRI potentially predicts late genitourinary toxicity after prostate cancer radiation","volume":"31","author":"Lee","year":"2024","journal-title":"Acad Radiol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13014-019-1424-8","article-title":"The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapy","volume":"14","author":"Dekura","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0021","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/mp.12830","article-title":"Changes in prostate orientation due to removal of a Foley catheter","volume":"45","author":"Litzenberg","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2026.05.001_bib0022","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijrobp.2007.12.052","article-title":"Segmental urethral dosimetry and urinary toxicity in patients with No urinary symptoms before permanent prostate brachytherapy","volume":"72","author":"Thomas","year":"2008","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0023","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brachy.2012.10.006","article-title":"An MRI-based dose\u2013response analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial","volume":"12","author":"Register","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2026.05.001_bib0024","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0360-3016(01)02658-X","article-title":"Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation","volume":"52","author":"Crook","year":"2002","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2010.01.022","article-title":"Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate","volume":"80","author":"Roeloffzen","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0026","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2026.05.001_bib0027","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/(SICI)1520-6777(1998)17:6<591::AID-NAU3>3.0.CO;2-9","article-title":"Magnetic resonance imaging of the male pelvic floor: the anatomical configuration and dynamic movement in healthy men","volume":"17","author":"Mikuma","year":"1998","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.brachy.2026.05.001_bib0028","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.juro.2008.01.010","article-title":"The male urethral sphincter Complex revisited: an anatomical concept and its physiological correlate","volume":"179","author":"Koraitim","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2026.05.001_bib0029","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0360-3016(01)01811-9","article-title":"The dosimetry of prostate brachytherapy-induced urethral strictures","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472126000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472126000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:33:49Z","timestamp":1792841629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472126000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1538472126000711"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2026.05.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urethral dosimetry and urinary symptoms after prostate brachytherapy: Analyzing key predictive factors","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}